Miltefosine Treatment of Cutaneous Leishmaniasis

Affiliations

¹ Fundación Nacional de Dermatología and Hospital Dermatológico de Jorochito, Santa Cruz, Bolivia.
² Fast-Track Drugs and Biologics LLC, North Potomac, Maryland, USA.

Editorial

Jaime A Soto et al. Clin Infect Dis. 2021.

. 2021 Oct 5;73(7):e2463-e2464.

doi: 10.1093/cid/ciaa1461.

¹ Fundación Nacional de Dermatología and Hospital Dermatológico de Jorochito, Santa Cruz, Bolivia.
² Fast-Track Drugs and Biologics LLC, North Potomac, Maryland, USA.

No abstract available

Keywords: cutaneous leishmaniasis; efficacy; miltefosine; tolerance.

Comment on

Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis.
Ware JM, O'Connell EM, Brown T, Wetzler L, Talaat KR, Nutman TB, Nash TE. Ware JM, et al. Clin Infect Dis. 2021 Oct 5;73(7):e2457-e2562. doi: 10.1093/cid/ciaa1238. Clin Infect Dis. 2021. PMID: 33124666 Free PMC article.